Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics Drugs. This report contains market size and forecasts of Peptide Therapeutics Drugs in global, including the following market information:
Global Peptide Therapeutics Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Peptide Therapeutics Drugs market was valued at US$ 35550 million in 2022 and is projected to reach US$ 63390 million by 2029, at a CAGR of 8.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
We surveyed the Peptide Therapeutics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Therapeutics Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Peptide Therapeutics Drugs Market Segment Percentages, by Type, 2022 (%)
Injection
Oral
Other
Global Peptide Therapeutics Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Peptide Therapeutics Drugs Market Segment Percentages, by Application, 2022 (%)
Cancer
Metabolic Disorders
Central Nervous System
Other
Global Peptide Therapeutics Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Peptide Therapeutics Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Therapeutics Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptide Therapeutics Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
JNJ
Tarix Pharmaceuticals
Lonza
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide Therapeutics Drugs, market overview.
Chapter 2: Global Peptide Therapeutics Drugs market size in revenue.
Chapter 3: Detailed analysis of Peptide Therapeutics Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peptide Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide Therapeutics Drugs Overall Market Size
2.1 Global Peptide Therapeutics Drugs Market Size: 2022 VS 2030
2.2 Global Peptide Therapeutics Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptide Therapeutics Drugs Players in Global Market
3.2 Top Global Peptide Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Peptide Therapeutics Drugs Revenue by Companies
3.4 Top 3 and Top 5 Peptide Therapeutics Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peptide Therapeutics Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide Therapeutics Drugs Players in Global Market
3.6.1 List of Global Tier 1 Peptide Therapeutics Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptide Therapeutics Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptide Therapeutics Drugs Market Size Markets, 2022 & 2030
4.1.2 Injection
4.1.3 Oral
4.1.4 Other
4.2 By Type - Global Peptide Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Peptide Therapeutics Drugs Revenue, 2018-2023
4.2.2 By Type - Global Peptide Therapeutics Drugs Revenue, 2024-2030
4.2.3 By Type - Global Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptide Therapeutics Drugs Market Size, 2022 & 2030
5.1.2 Cancer
5.1.3 Metabolic Disorders
5.1.4 Central Nervous System
5.1.5 Other
5.2 By Application - Global Peptide Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Peptide Therapeutics Drugs Revenue, 2018-2023
5.2.2 By Application - Global Peptide Therapeutics Drugs Revenue, 2024-2030
5.2.3 By Application - Global Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Peptide Therapeutics Drugs Market Size, 2022 & 2030
6.2 By Region - Global Peptide Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Peptide Therapeutics Drugs Revenue, 2018-2023
6.2.2 By Region - Global Peptide Therapeutics Drugs Revenue, 2024-2030
6.2.3 By Region - Global Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Peptide Therapeutics Drugs Revenue, 2018-2030
6.3.2 US Peptide Therapeutics Drugs Market Size, 2018-2030
6.3.3 Canada Peptide Therapeutics Drugs Market Size, 2018-2030
6.3.4 Mexico Peptide Therapeutics Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Peptide Therapeutics Drugs Revenue, 2018-2030
6.4.2 Germany Peptide Therapeutics Drugs Market Size, 2018-2030
6.4.3 France Peptide Therapeutics Drugs Market Size, 2018-2030
6.4.4 U.K. Peptide Therapeutics Drugs Market Size, 2018-2030
6.4.5 Italy Peptide Therapeutics Drugs Market Size, 2018-2030
6.4.6 Russia Peptide Therapeutics Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Peptide Therapeutics Drugs Market Size, 2018-2030
6.4.8 Benelux Peptide Therapeutics Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Peptide Therapeutics Drugs Revenue, 2018-2030
6.5.2 China Peptide Therapeutics Drugs Market Size, 2018-2030
6.5.3 Japan Peptide Therapeutics Drugs Market Size, 2018-2030
6.5.4 South Korea Peptide Therapeutics Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Peptide Therapeutics Drugs Market Size, 2018-2030
6.5.6 India Peptide Therapeutics Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Peptide Therapeutics Drugs Revenue, 2018-2030
6.6.2 Brazil Peptide Therapeutics Drugs Market Size, 2018-2030
6.6.3 Argentina Peptide Therapeutics Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptide Therapeutics Drugs Revenue, 2018-2030
6.7.2 Turkey Peptide Therapeutics Drugs Market Size, 2018-2030
6.7.3 Israel Peptide Therapeutics Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Peptide Therapeutics Drugs Market Size, 2018-2030
6.7.5 UAE Peptide Therapeutics Drugs Market Size, 2018-2030
7 Peptide Therapeutics Drugs Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Peptide Therapeutics Drugs Major Product Offerings
7.1.4 Sanofi Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Peptide Therapeutics Drugs Major Product Offerings
7.2.4 Eli Lilly Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Novo Nordisk
7.3.1 Novo Nordisk Company Summary
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Peptide Therapeutics Drugs Major Product Offerings
7.3.4 Novo Nordisk Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.3.5 Novo Nordisk Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Company Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Peptide Therapeutics Drugs Major Product Offerings
7.4.4 Takeda Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.4.5 Takeda Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Peptide Therapeutics Drugs Major Product Offerings
7.5.4 Teva Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Peptide Therapeutics Drugs Major Product Offerings
7.6.4 Novartis Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Peptide Therapeutics Drugs Major Product Offerings
7.7.4 AstraZeneca Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Ipsen
7.8.1 Ipsen Company Summary
7.8.2 Ipsen Business Overview
7.8.3 Ipsen Peptide Therapeutics Drugs Major Product Offerings
7.8.4 Ipsen Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.8.5 Ipsen Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Peptide Therapeutics Drugs Major Product Offerings
7.9.4 AbbVie Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.9.5 AbbVie Key News & Latest Developments
7.10 Allergan
7.10.1 Allergan Company Summary
7.10.2 Allergan Business Overview
7.10.3 Allergan Peptide Therapeutics Drugs Major Product Offerings
7.10.4 Allergan Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.10.5 Allergan Key News & Latest Developments
7.11 Ferring
7.11.1 Ferring Company Summary
7.11.2 Ferring Business Overview
7.11.3 Ferring Peptide Therapeutics Drugs Major Product Offerings
7.11.4 Ferring Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.11.5 Ferring Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Peptide Therapeutics Drugs Major Product Offerings
7.12.4 Merck Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
7.13 JNJ
7.13.1 JNJ Company Summary
7.13.2 JNJ Business Overview
7.13.3 JNJ Peptide Therapeutics Drugs Major Product Offerings
7.13.4 JNJ Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.13.5 JNJ Key News & Latest Developments
7.14 Tarix Pharmaceuticals
7.14.1 Tarix Pharmaceuticals Company Summary
7.14.2 Tarix Pharmaceuticals Business Overview
7.14.3 Tarix Pharmaceuticals Peptide Therapeutics Drugs Major Product Offerings
7.14.4 Tarix Pharmaceuticals Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.14.5 Tarix Pharmaceuticals Key News & Latest Developments
7.15 Lonza
7.15.1 Lonza Company Summary
7.15.2 Lonza Business Overview
7.15.3 Lonza Peptide Therapeutics Drugs Major Product Offerings
7.15.4 Lonza Peptide Therapeutics Drugs Revenue in Global Market (2018-2023)
7.15.5 Lonza Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peptide Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 2. Peptide Therapeutics Drugs Market Drivers in Global Market
Table 3. Peptide Therapeutics Drugs Market Restraints in Global Market
Table 4. Key Players of Peptide Therapeutics Drugs in Global Market
Table 5. Top Peptide Therapeutics Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Peptide Therapeutics Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Peptide Therapeutics Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Peptide Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Peptide Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Peptide Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Peptide Therapeutics Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Peptide Therapeutics Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Peptide Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Peptide Therapeutics Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Peptide Therapeutics Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Peptide Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Peptide Therapeutics Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Peptide Therapeutics Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Peptide Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Peptide Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Peptide Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Peptide Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Peptide Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Sanofi Company Summary
Table 31. Sanofi Peptide Therapeutics Drugs Product Offerings
Table 32. Sanofi Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Peptide Therapeutics Drugs Product Offerings
Table 36. Eli Lilly Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. Novo Nordisk Company Summary
Table 39. Novo Nordisk Peptide Therapeutics Drugs Product Offerings
Table 40. Novo Nordisk Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novo Nordisk Key News & Latest Developments
Table 42. Takeda Company Summary
Table 43. Takeda Peptide Therapeutics Drugs Product Offerings
Table 44. Takeda Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Takeda Key News & Latest Developments
Table 46. Teva Company Summary
Table 47. Teva Peptide Therapeutics Drugs Product Offerings
Table 48. Teva Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Teva Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Peptide Therapeutics Drugs Product Offerings
Table 52. Novartis Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Peptide Therapeutics Drugs Product Offerings
Table 56. AstraZeneca Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Ipsen Company Summary
Table 59. Ipsen Peptide Therapeutics Drugs Product Offerings
Table 60. Ipsen Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Ipsen Key News & Latest Developments
Table 62. AbbVie Company Summary
Table 63. AbbVie Peptide Therapeutics Drugs Product Offerings
Table 64. AbbVie Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. AbbVie Key News & Latest Developments
Table 66. Allergan Company Summary
Table 67. Allergan Peptide Therapeutics Drugs Product Offerings
Table 68. Allergan Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Allergan Key News & Latest Developments
Table 70. Ferring Company Summary
Table 71. Ferring Peptide Therapeutics Drugs Product Offerings
Table 72. Ferring Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Ferring Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Peptide Therapeutics Drugs Product Offerings
Table 76. Merck Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. JNJ Company Summary
Table 79. JNJ Peptide Therapeutics Drugs Product Offerings
Table 80. JNJ Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. JNJ Key News & Latest Developments
Table 82. Tarix Pharmaceuticals Company Summary
Table 83. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product Offerings
Table 84. Tarix Pharmaceuticals Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Tarix Pharmaceuticals Key News & Latest Developments
Table 86. Lonza Company Summary
Table 87. Lonza Peptide Therapeutics Drugs Product Offerings
Table 88. Lonza Peptide Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Lonza Key News & Latest Developments
List of Figures
Figure 1. Peptide Therapeutics Drugs Segment by Type in 2022
Figure 2. Peptide Therapeutics Drugs Segment by Application in 2022
Figure 3. Global Peptide Therapeutics Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Peptide Therapeutics Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Peptide Therapeutics Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2022
Figure 8. By Type - Global Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Peptide Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Peptide Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 16. US Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 28. China Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Peptide Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Peptide Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Sanofi Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novo Nordisk Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Takeda Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teva Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Ipsen Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. AbbVie Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Allergan Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Ferring Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. JNJ Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Tarix Pharmaceuticals Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Lonza Peptide Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
